Browse Articles
Discover research articles across all indexed journals
Wave propagation in fluid-saturated nanoporous media: Upscaling molecular mechanics into continuum-level description
Understanding how mechanical, thermodynamic, and acoustic properties emerge in fluid-saturated nanoporous materials remains a major challenge due to the breakdown of classical continuum assumptions at molecular length scales. Here, we present a multiscale framework that extends linear chemo-poroelasticity theory to describe the coupled response of nanoporous solids and confined fluids to mechanical wave excitation. The effective poromechanical parameters—elasticity and stress-chemistry coupling tensors, scalar chemistry modulus, and fluid mobility tensor—are computed from atomistic simulations of methane adsorption and transport in a prototypical zeolite. These simulation-informed parameters are then embedded in a continuum model of mechanical wave propagation. This integrated approach enables the prediction of the effective wave speeds and attenuation as a function of frequency, fluid loading, and nanopore-scale structure. The methodology provides a physically grounded path for linking molecular interactions to macroscopic acoustic and elastic response. In turn, this framework offers opportunities for designing nanoporous materials with tailored transport, mechanical, and acoustical properties—particularly in the emerging field of nanoscale acoustics.
Biophysical fitness landscape design traps viral evolution
Evolutionary adaptation is often visualized as a population’s stochastic climb toward the top of a fitness landscape. While there exist approaches to design or synthetically evolve proteins into desired structures, there is a lack of methodology for designing, tuning, and quantitatively reshaping the fitness landscapes themselves on which protein evolution takes place. Here, we introduce foundational principles of fitness landscape design (FLD) to customize the structural peaks and valleys of biophysical fitness landscapes with quantitative accuracy, offering robust control of long-term evolutionary outcomes. Our FLD algorithms use stochastic optimization of a chemically derived biophysical fitness model to consistently discover optimal antibody ensembles which force a target protein to evolve according to a user-specified target fitness landscape. We then apply FLD to suppress the fitnesses of two SARS-CoV-2 genotype neutral networks and to discover proactive vaccines that preemptively restrict escape variant fitness trajectories before they arise.
Cryo-EM of the eukaryotic purine transporter UapA demonstrates intramolecular and lipid regulation of transport
Members of the nucleobase ascorbate transporter (NAT) family (SLC23) are elevator-type transporters that are responsible for the uptake of nucleobases and ascorbate. In fungi, NAT members are also responsible for the specific uptake of antifungal nucleobase analogues, such as oxypurinol, allopurinol, or 8-azaguanine. Here, we report nearly full-length cryo-EM structures of UapA, a high-affinity purine transporter from the model fungus Aspergillus nidulans , in inward-facing apo- and substrate-loaded conformations at 2.06 to 3.5 Å in detergent and lipid nanodiscs. The high-resolution structures reveal the role of water molecules and lipids in substrate binding, specificity, transporter dimerization, and activity. Notably, the N-tail of UapA is found to be structured, interacting with both the core and scaffold domains, which in combination with functional data suggests a dual role in trafficking and transport dynamics. Overall, our study provides unprecedented structural and functional insights into an elevator-type fungal transporter, which may well contribute to the exploitation of NAT transporters as specific gateways for targeted pharmacological antifungal approaches.
Knotted solid tori in contact manifolds
In this paper, we study solid tori in contact manifolds. Specifically, we study the contact width of a knot type and give criteria for when it can be explicitly computed. We also prove there are many “nonthickenable” tori in many knot types. These tori are frequently essential in the study of Legendrian and transverse knot theory and tight contact structures on manifolds obtained by surgery on the knot. Previously, nonthickenable tori have only been observed for iterated torus knots in S 3 and were thought to be rare. We show that they are quite common, exist in other manifolds, and even for a hyperbolic knot in S 3 . We also make and highlight several conjectures about the general nature of knots in contact manifolds.
Collagen-producing eye cell atlas reveals distinct fibroblast fates in early injury vs. fibrotic subretinal disease
Fibrosis is the end-stage of a maladaptive process that occurs when the body’s normal wound-healing strategy becomes dysregulated. Subretinal fibrosis is the end stage of neovascular age-related macular degeneration (nAMD), the most common cause of central vision loss in people over the age of 50. The cellular sources of excess extracellular matrix (ECM) contributing to subretinal fibrosis are unknown, as is the heterogeneity of cells involved in the fibrotic process. Here we identify cells contributing to subretinal fibrosis by using Col1a1 -YFP reporter mice to noninvasively image collagen production in real-time in vivo in two disease models, 1) a resolving retinal injury model and 2) a fibrotic model of subretinal disease. We create a collagen-producing eye cell atlas for subretinal injury and demonstrate subretinal fibroblast heterogeneity in healthy, resolving, and fibrotic tissue. We identify distinct molecular characteristics of general repair/resolving fibroblast populations versus pathogenic pro-fibrotic collagen-producing fibroblasts. Integration of this collagen-producing eye cell atlas with a published collagen-producing lung cell atlas shows conserved pro-fibrotic fibroblasts in both organs, yet also uncovers tissue-specific fibroblast populations unique to subretinal fibrosis. A Fap + Fgl2 + fibroblast population significantly expands in subretinal fibrosis that expresses the highest levels of collagens and distinctively expresses ECM components Periostin , Col15a1 and Col6a5 . Immunolabeling of mouse and human-donor eye tissue support the fibroblastic expression and perivascular location of periostin as clearly distinguishing between bona fide fibrosis and early disease in nAMD. Our collagen-producing eye cell atlas is a valuable resource for studying distinct fibroblast subsets in homeostasis, early injury, and fibrosis.
Exploring memory effects: Sparse identification in vector-borne diseases
Predicting the human burden of vector-borne diseases from limited surveillance data remains a major challenge, particularly in the presence of nonlinear transmission dynamics and delayed effects arising from vector ecology and human behavior. We develop a data-driven framework based on an extension of Sparse Identification of Nonlinear Dynamics to systems with distributed memory, enabling discovery of transmission mechanisms directly from time series data. Using severe fever with thrombocytopenia syndrome as a case study, we show that this approach can uncover key features of tick-borne disease dynamics using only human incidence and local temperature data, without imposing predefined assumptions on human case reporting. We further ascertain the robustness of the recovered incidence-temperature model by integrating it with mechanistically derived tick–host covariates, showing that the forecasting ability does not improve. This suggests that the proposed core data-driven model already delivers strong predictions. The framework also allows for systematic sensitivity analysis of memory kernels and behavioral parameters. Although the approach prioritizes predictive accuracy over mechanistic transparency, it yields sparse, interpretable integral representations suitable for epidemiological forecasting. This methodology provides a scalable strategy for forecasting vector-borne disease risk and informing public health decision-making under data limitations.
On the origin of PRDM9-guided recombination hotspots
Meiotic recombination is highly conserved across vertebrates and plays an essential role in ensuring chromosomal segmentation and generating genomic variation. However, species employ two strikingly different mechanisms to guide recombination. In most mammals, recombination hotspot locations are determined by the protein PRDM9, which binds specific DNA sequence motifs. These motifs are rapidly eroded by biased gene conversion, rendering this mechanism self-destructive and evolutionarily transient. In contrast, birds initiate recombination at open chromatin regions independently of sequence motifs, producing self-preserving and evolutionarily stable recombination hotspots. Some species use both types of hotspots simultaneously, raising the unresolved question of why PRDM9-guided hotspots persist alongside a robust alternative. Here, we address this problem using a population genetic model that explicitly considers competition between PRDM9-guided and non-PRDM9-guided recombination hotspots. We show that non-PRDM9-guided hotspots are generally favored because, lacking sequence specificity, they generate more crossovers required for proper chromosome segregation. However, PRDM9-guided hotspots can overcome this disadvantage when simultaneous binding of both homologous chromosomes (symmetric binding) is more likely to resolve as crossovers than binding of a single homolog (asymmetric binding). Although PRDM9 reduces overall crossover rate, its sequence specificity increases the probability of symmetric binding within hotspots, creating a trade-off that can favor PRDM9 under specific selection regimes. Our model predicts that PRDM9-dependent species are particularly sensitive to disruptions of symmetric binding, whereas species lacking PRDM9 are more vulnerable to complete crossover failure. Intermediate regimes allow stable coexistence of both hotspot types.
CD4+CD25+FOXP3+ Regulatory T Cells to Protect Against Graft Versus Host Disease
Allogeneic hematopoietic cell transplantation (HCT) has benefited many patients with hematological malignancies and bone marrow failure states. However, graft vs host disease (GVHD) and immune incompetence remain significant challenges that limit the field to the treatment of patients with life threatening, high-risk disorders due to the significant non-relapse mortality (NRM) associated with the treatment. With a greater understanding of the pathophysiology of GVHD it has become apparent that this disorder represents a dysregulated immune reaction resulting in immune dysfunction further exacerbated by the treatment with immunosuppressive medications and injury to lymphoid tissues where immune recovery and tolerance develop. The emergence of fundamental mechanisms of immune regulation, whose pioneers received the 2025 Nobel Prize in Physiology and Medicine, have resulted in new concepts for improving outcomes for patients and the hope that with reduction in transplant related risk HCT can be offered to more patients with a broader range of immune mediated disorders. In this review the history, preclinical studies and successful translation of CD4+CD25+FoxP3+ regulatory T cells (Treg) in the context of allogeneic HCT will be discussed.
Rheologic controls on the depth dependence of megathrust earthquakes
The various slip behaviors of the subduction megathrust fault, including deadly megathrust earthquakes, are depth-dependent. Yet, we do not know what causes this depth dependence, in part due to variability between subduction zone thermal structures and lithological inputs. Here, we investigate controls on the nucleation depths of great earthquakes (Mw ≳ 8) and the deeper extent of seismogenesis. To do so, we create rheologic strength envelopes for six subduction zones using published constitutive relations for subducting lithologies and regional thermal models. We then compare the strength envelopes to local plate interface earthquake depths. Our synthesis shows that subducted sediments undergo a transition from frictional to predominantly viscous deformation near 300 ± 60 ° C a transition that correlates with the maximum nucleation depths of great earthquakes at 20 to 30 km. However, smaller plate interface earthquakes ( 5 ≤ Mw < 8) continue to nucleate below this depth, and the maximum earthquake size decreases until the base of the seismogenic zone at 40 to 60 km depth and ∼ 500 °C. We evaluate potential causes of seismicity below the onset of viscous deformation in these now metasediments, and conclude that the presence of lithologic heterogeneities that are loaded to frictional failure by viscously deforming metasediments is most plausible. Thus, we propose that great earthquakes can nucleate and grow into large events where all lithologies are frictional. However, the base of the seismogenic zone is deeper than the onset of viscous deformation in metasediments, which limits the growth of earthquakes into large events, and here seismicity reflects the existence and size of heterogeneity along the plate interface.
Phosphorylated DEK sustains leukemia stem cells by enabling PBX3-driven transcriptional reprogramming
Leukemia stem cells (LSCs) drive acute myeloid leukemia (AML) initiation, relapse, and chemoresistance, yet the core post-translational events sustaining LSC maintenance remain poorly defined. Here, through phosphoproteomic profiling of normal hematopoietic stem and progenitor cells (HSPCs) versus LSC-enriched populations, we identify DEK phosphorylation as a critical modification during leukemogenesis. Functional studies in MLL-AF9- and HOXA9/MEIS1-driven AML mouse models, as well as patient-derived xenografts (PDXs), demonstrate that DEK deficiency impairs LSC maintenance and AML progression. Moreover, DEK deletion enhances LSC chemosensitivity to the standard-of-care combination of azacitidine and venetoclax (Aza/Ven), whereas DEK overexpression confers robust chemoresistance. Mechanistically, DEK recruits the transcription factor GABPA to upregulate the transcriptional cofactor PBX3, a key oncogenic driver in AML, thereby sustaining the leukemogenic transcriptional program. This DEK-GABPA interaction strictly depends on DEK phosphorylation at Ser301/303/306/307 (the 4S sites), which stabilizes the conformation of the DEK-GABPA complex. We identify casein kinase 2 (CK2) as the upstream kinase that directly phosphorylates DEK-4S sites. Importantly, blockade of DEK phosphorylation via 4S site mutagenesis or treatment with the clinical-stage CK2 inhibitor CX-4945 selectively depletes LSCs while sparing normal HSPCs. Furthermore, combining CX-4945 with venetoclax promotes LSC apoptosis and represses the PBX3-driven leukemogenic transcriptional program, exhibiting synergistic anti-AML effects both in vitro and in vivo. Collectively, our findings uncover a previously unrecognized phosphorylation event (DEK-4S phosphorylation) that sustains LSCs and establish the CK2-DEK axis as a promising LSC-specific therapeutic strategy for AML.
HDAC inhibition sensitizes pancreatic tumors to DNA damage by global redistribution of the transcriptional machinery
The DNA damage response (DDR) is critical for pancreatic ductal adenocarcinoma (PDAC) development and therapeutic responses, including to genotoxic agents. While epigenetic modulators have been shown to contribute to the DDR, how chromatin regulation dictates responses to DNA damage in PDAC remains incompletely understood. Here, we identify Class I histone deacetylases (HDACs) as critical regulators of the DDR. HDAC1/2 direct the genomic distribution of H3K27ac, ensuring sufficient BRD4 and RNA polymerase II (Pol II) occupancy at DDR gene promoters. HDAC inhibition by entinostat shifts the balance of H3K27 acetylation preferentially toward intergenic regions, diverting BRD4 and Pol II from promoters, thereby suppressing DDR gene expression. In line with this, HDAC inhibition heightens DNA damage and sensitizes PDAC to diverse DNA-damaging and DDR-targeting agents. Since the clinical development of HDAC inhibitors has been limited by systemic toxicity, we developed bottlebrush prodrug (BPD) nanoparticles for tumor-selective entinostat delivery. Entinostat-BPD achieved tumor-specific HDAC inhibition while displaying potent efficacy and reduced systemic toxicity. These findings reveal an HDAC-dependent DDR vulnerability and offer combinational and precision targeting strategies to facilitate clinical translation and improve PDAC patient outcomes.
A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL
Primary cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of extranodal non-Hodgkin lymphomas. Outcomes for patients with advanced-stage disease are suboptimal, as few complete and durable responses are achieved with currently available therapeutic agents. However, improved understanding of oncogenic transcriptional programs in malignant T cells and their engagement with the tumor microenvironment (TME) may unveil therapeutic vulnerabilities. Therefore, we have compiled the largest available scRNA-seq CTCL atlas that includes &gt;2 million skin and blood cells from 116 individual patients. We identified recurrent transcriptional programs in malignant T cells, a subset of which are associated with GATA-3 dependent transcriptional programs, especially in the setting of large cell transformation and advanced-stage disease. Many of the transcriptional programs identified are therapeutically targetable with clinically available agents, including HDAC, XPO1, CDK9, JAK/CSF1R, and IKZF1/IKZF3 antagonists. The CTCL TME is dominated by infiltrating and exhausted effector and cytotoxic T cells that are restrained by a robust infiltrate of regulatory T cells, transcriptionally polarized monocytes/macrophages, and cancer-associated fibroblasts. Collectively, these findings have significant implications for the rationale design of combinatorial strategies targeting immune checkpoints, including PD-1. We have identified transcriptional programs, driven by oncogenic transcription factors, and constituents of the TME as therapeutic vulnerabilities in CTCL, and hope that the CTCL atlas constructed will provide a valuable resource for future studies exploiting these therapeutic vulnerabilities.
Large cities lose their growth advantage as countries urbanize
The share of the world population living in cities with more than one million people rose from 11% in 1975 to 24% in 2025 (our estimates). Will this trend toward greater concentration in large cities continue or level off? We introduce two new city population datasets that use consistent city definitions across countries and over time. The first covers the world between 1975 and 2025, using satellite imagery. The second covers the United States between 1850 and 2020, using census microdata. We find that urban growth follows a characteristic life cycle. In the early stages of a country’s urbanization process, large cities grow faster than smaller ones. At later stages, growth rates equalize across sizes. We use this life cycle to project future population concentration in large cities. Our projections suggest that 38% of the world population will be living in cities with more than one million people by 2100. This estimate is higher than the 33% implied by the well-known theory of proportional growth, but lower than the 42% obtained by extrapolating current trends.
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder
Antiphospholipid syndrome (APS) is an immunothrombotic disorder, frequently attributed to autoantibodies that bind β2-glycoprotein I (β2GPI). A study showed that the platelet-specific chemokine, platelet factor 4 (PF4), binds to β2GPI, enhancing recognition of β2GPI by APS antibodies. APS antibodies induce the release of neutrophil extracellular traps (NETs), webs of decondensed chromatin that bind both PF4 and b2GPI. We propose that PF4 bridges β2GPI to NETs (and other PF4-targeted polyanions), leading to the formation of prothrombotic PF4:b2GPI:NET immunotargets in APS. Dynamic light-scattering studies of isolated IgGs from four patients with triple-positive APS show formation of PF4:β2GPI:NET complexes that bind APS antibodies. NETs released in a microfluidic system bound b2GPI, but only in the presence of PF4, forming a multimolecular APS antigenic target. Whole blood infused through a photochemically-injured, endothelium-lined microfluidic channel formed platelet-, fibrin-, and complement- rich thrombi that bound APS antibody only in the presence of PF4. Thrombi were reduced in size if either ADAMTS13 or DNase1 was infused. In a murine APS model, wildtype and transgenic mice expressing platelet human PF4 ± FcgRIIA developed more intense neutrophil rolling along veins, and more extensive thrombus formation following laser injury to cremaster arterioles and venules, whereas mice lacking PF4 did not. Three antigenically distinct anti-hPF4 monoclonal antibodies blocked thrombosis in vitro, and neutrophil rolling and thrombosis in vivo. Our studies provide new insights into the basis of APS that has mechanistic parallels to other known PF4 immunothrombotic disorders and offer potential diagnostic and non-anticoagulant therapeutic strategies for clinical management.
Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets
Natural hallucinogenic compounds have arisen independently across plants, fungi, and animals, evolving into a diverse chemical arsenal that includes phenethylamines, indolealkylamines, and terpenoid scaffolds. Beyond clinical and cultural frameworks, their ecological origins and evolutionary trajectories may help explain why such potent modulators of perception, emotion, and cognition persist in nature. Here, integrating chemical ecology, comparative genomics, biosynthetic logic, and evolutionary biology, we propose that these molecules may function as defensive agents or symbiosis-associated manipulators of herbivore and pollinator behavior. A “building-block” biosynthetic logic links primary metabolism to convergent psychotropic scaffolds via a recurrent set of tailoring reactions, including decarboxylations and methylations. Recent advances illuminate mescaline biosynthesis in cacti, horizontal gene transfer of psilocybin clusters in fungi, and symbiont-derived alkaloids in grasses. We also assess the debate surrounding endogenous mammalian tryptamines, arguing that the leading hypothesis points toward sigma-1 receptor-mediated cytoprotection and stress responses, supported by convergent pharmacological and cellular evidence, rather than inherent hallucinogenic functions. Across kingdoms, natural hallucinogens appear to converge on conserved neural targets, including serotonergic and other neuromodulatory systems that are shared across phyla. From this perspective, human psychoactivity is likely an evolutionary by-product of molecules selected for ecological interactions with animals possessing deeply conserved receptor architectures. Framing hallucinogens through chemical ecology not only clarifies their origins but also highlights translational opportunities in target discovery, pathway engineering, and sustainable production, while emphasizing the need to integrate conservation, ethical sourcing, and benefit-sharing into the current hallucinogenic renaissance.
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis
The Phase 3 TRANSFORM-1 study (NCT04472598) evaluated ruxolitinib (RUX) in combination with navitoclax (NAV) or placebo (PBO) in Janus-kinase-inhibitor-naïve adults with intermediate-2 or high-risk myelofibrosis and Eastern Cooperative Oncology Group performance status ≤2. Patients were randomized 1:1 to NAV (200 mg/day starting dose or 100 mg escalated to 200 mg/day) or PBO, with RUX dosed per label. The primary endpoint was ≥35% spleen volume reduction (SVR) at Week 24 (SVR35W24). Secondary endpoints included change from baseline in Total Symptom Score (TSS) at Week 24 and SVR35 at any time. A total of 252 patients (NAV+RUX, n=125; PBO+RUX, n=127; median follow-up 20.3 months) were randomized; &gt;80% had intermediate-2 risk and nearly 50% were high-molecular risk (HMR). SVR35W24 was achieved by 63.2% with NAV+RUX versus 31.5% with PBO+RUX (P&lt;0.0001). Mean change in TSS at Week 24 was not significantly different between NAV+RUX and PBO+RUX (−10.2 vs −11.6; P=0.2852). SVR35 at any time was achieved in 76.8% with NAV+RUX versus 44.1% with PBO+RUX (nominal P&lt;0.0001). A ≥20% variant allele frequency reduction (exploratory endpoint) occurred in 58.5% (95% CI: 49.0-67.5) with NAV+RUX and 45.5% (95% CI: 36.4-54.8) with PBO+RUX. NAV+RUX showed higher hematologic toxicity versus PBO+RUX (Grade 3/4 thrombocytopenia: 54.0% vs 19.2%; Grade 3/4 neutropenia: 40.3% vs 8.8%); diarrhea (any grade: 41.9% vs 16.8%) was also more common. Cytopenias were generally manageable and reversible with dose adjustments.
Temperature and developmental stage govern intestinal susceptibility to human coronavirus 229E
Human coronaviruses have been primarily associated with upper respiratory tract infections, yet cases of gastrointestinal symptoms in COVID-19 patients have highlighted their potential to cause systemic disease. Here, we detail the infection of intestinal epithelia by an endemic, low-pathogenic human coronavirus, human alphacoronavirus 229E, using patient-derived human intestinal enteroids (HIEs) from donors of various ages. Using fetal, pediatric, and adult HIEs, we investigated how physiologically relevant temperatures: 37 °C and 32 °C, reflecting gastrointestinal and upper-airway conditions, respectively, modulate epithelial responses and viral infection dynamics. We show that there is temperature-dependent transcriptional reprogramming, indicating strong temperature-dependent regulation of virus replication and epithelial responses. Among the seasonal coronaviruses tested, only HCoV-229E productively infects HIEs. At 32 °C, HCoV-229E replicates efficiently in enteroids from all donor ages and releases high titers of infectious progeny. In contrast, at 37 °C, productive replication is largely confined to fetal and a subset of pediatric tissues, revealing a developmental and temperature-sensitive restriction on infection. Confocal and flow cytometry analyses identify enterocytes as the primary target cells for HCoV-229E. Furthermore, we show that camostat, a serine protease inhibitor, significantly reduces HCoV-229E replication in HIEs, confirming a critical role for host serine protease activity. Collectively, these findings establish HIEs as a relevant model for HCoV-229E–host interactions and reveal temperature- and age-dependent determinants governing intestinal permissiveness to this seasonal coronavirus.
Profile of John P. Smol
John P. Smol has spent more than four decades demonstrating how lake sediment cores can reveal environmental changes spanning decades to centuries. His pioneering work established paleolimnology as a credible scientific discipline, first, by documenting the impact of acid rain on North American lakes in the 1980s and, later, by tracking Arctic climate warming. Through continuous monitoring of High Arctic ponds and lakes, Smol has shown how ice cover duration influences aquatic ecosystems. His recent research reveals that even the deepest Arctic lakes are now crossing ecological thresholds due to accelerated warming, with implications for Indigenous fisheries and northern communities.
A potential overestimation of CO <sub>2</sub> physiological effects on evapotranspiration
It is generally believed that CO 2 physiological forcing can partially mitigate land surface drying under global warming by reducing stomatal conductance and evapotranspiration. Most of this type of study focuses on the direct regulation by vegetation physiology, overlooking interactive feedback from the atmosphere. Using fully coupled earth system model simulations, we find that the physiological benefit may have been optimistically overestimated. Vegetation-induced energy change may in turn further affect atmospheric vapor pressure deficit (VPD), exerting extra evapotranspiration demand indirectly. Indirect VPD feedback over northern mid-high latitudes could offset 54% (±26%) of evapotranspiration reduction driven by stomatal closure under current CO 2 condition, and that proportion increases to 68% (±18%) at 4 × CO 2 . The enhanced VPD feedback is largely driven by vegetation-mediated albedo decline and temperature rise in northern mid-high latitudes, which intensifies evapotranspiration loss as stomatal constraints are minimal. These are important findings, substantially limiting the physiological benefits of CO 2 with extra pressure on surface aridification and water resources.
Adaptive mechanochemical mechanisms of the nucleus during confined cell migration
Cell migration through spatially confined microenvironments occurs in many biological processes such as embryonic development, immune surveillance, and cancer metastasis. A major bottleneck during such migration is the nucleus, which acts not only as a rigid mechanical obstacle but also as a crucial mechanosensor that modulates downstream signaling pathways. However, it remains poorly understood how nuclear deformation and mechanosensation together regulate cell migration through confined spaces. Here, we propose a three-dimensional (3D) mechanochemical model of confined nuclear translocation that integrates nuclear deformation with deformation-induced calcium signaling and subsequent regulation of cytoskeletal contractility. We show that cells undergo adaptive nuclear deformation, including nuclear envelope elongation and 3D buckling, to efficiently navigate confinements of varying sizes. There exists a biphasic relation between nuclear velocity and confinement size, arising from the interplay between nuclear deformability and mechanosensitive feedback. We demonstrate that local nuclear envelope rupture can occur under large deformation, enabling nuclear translocation through extreme confinements, as observed in prior experiments. Furthermore, we elucidate the critical roles of chromatin organization in nuclear translocation. This work reveals key mechanochemical mechanisms driving confined cell migration and provides a theoretical framework for studying nuclear dynamics across physiological and pathological contexts.